{{Rsnum
|rsid=6545977
|Chromosome=2
|position=63074029
|Orientation=plus
|GMAF=0.4293
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 18.6 | 61.1 | 20.4
| HCB | 8.8 | 38.7 | 52.6
| JPT | 3.5 | 25.7 | 70.8
| YRI | 19.2 | 54.1 | 26.7
| ASW | 24.6 | 40.4 | 35.1
| CHB | 8.8 | 38.7 | 52.6
| CHD | 6.5 | 29.9 | 63.6
| GIH | 9.9 | 40.6 | 49.5
| LWK | 27.5 | 52.3 | 20.2
| MEX | 19.3 | 49.1 | 31.6
| MKK | 18.1 | 55.5 | 26.5
| TSI | 32.7 | 47.5 | 19.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19767753
|Trait=Prostate cancer
|Title=Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
|RiskAllele=A
|Pval=5E-7
|OR=NR
|ORtxt=NR
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6545977
|overall_frequency_n=57
|overall_frequency_d=128
|overall_frequency=0.445312
|n_genomes=34
|n_genomes_annotated=0
|n_haplomes=48
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}